TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
DHR

Danaher Corporation

Healthcare · Diagnostics & Research

224.50$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement DHR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
47.3% 45.2% 44.4% 44.2% 44.2% 44.3% 44.0% 39.0% 39.2% 51.1% 40.5% 39.1%
52.7% 54.8% 55.6% 55.8% 55.8% 55.7% 56.0% 61.0% 60.8% 58.7% 59.5% 60.9%
6.6% 6.0% 5.8% 6.2% 6.2% 6.3% 6.0% 5.9% 5.7% 6.3% 6.6% 6.5%
28.6% 41.9% 33.2% 33.0% 38.0% 31.2% 30.9% 27.8% 32.0% 36.3% 32.5% 33.5%
34.6% 38.1% 37.9% 38.6% 37.7% 37.0% 36.6% 33.6% 32.5% 37.0% 37.8% 40.0%
18.1% 16.8% 17.7% 17.2% 18.0% 18.8% 19.4% 27.3% 28.3% 21.8% 21.7% 20.9%
0.6% 1.0% 1.1% 0.9% 0.8% 0.6% 1.2% 0.8% 0.8% 1.2% 1.2% 1.1%
17.5% 14.1% 15.5% 16.0% 17.4% 18.5% 20.2% 25.8% 26.8% 21.1% 19.5% 17.2%
4.4% 2.0% 2.7% 2.6% 3.3% 4.9% 3.8% 4.2% 3.1% 1.3% 3.1% 2.5%
13.0% 18.0% 15.1% 13.6% 15.5% 14.3% 16.4% 21.8% 27.1% 19.9% 16.3% 14.7%
22.8% 21.2% 23.2% 23.7% 25.1% 25.7% 29.4% 34.0% 35.6% 21.8% 30.5% 28.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?